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Abstract - Hepatitis C virus (HCV) is a widely spread disease all 
over the world. HCV has very high mutation rate that makes it 
resistant to antibodies. Modeling HCV to identify the virus 
mutation process is essential to its detection and predicting its 
evolution. This paper presents a model based framework for 
estimating mutation rate of HCV in two steps. Firstly profile 
hidden Markov model (PHMM) architecture was builder to 
select the sequences which represents sequence per year. 
Secondly mutation rate was calculated by using pair-wise 
distance method between sequences.  A pilot study is conducted 
on NS5B zone of HCV dataset of genotype 4 subtype a (HCV4a) 
in Egypt. 
Keywords: Hepatitis C virus (HCV), Profile Hidden Markov 
Model (PHMM), Non-structure 5 B(NS5B), Phylogenetic tree, 
pair-wise distance. 
I. INTRODUCTION 
Once hepatitis C virus (HCV) has been discovered, it has 
been an importance subject of research and clinical 
investigations as its major role in human disease has emerged. 
An estimated 170 million people (3% of the world’s 
population) worldwide have hepatitis C virus (HCV) infection 
and creates a huge disease burden from chronic, progressive 
liver disease [1]. Hepatitis C is a predominant genotype found 
throughout the Middle East and parts of Africa, with high 
population prevalence in Egypt. Due to the world’s constant 
effort to find treatment for this fatal disease; many researches 
and trials have been made [2]. HCV has become a major 
cause of liver cancer and one of the commonest indications 
for liver transplantation. HCV infection can be treated, but 
this is costly and requires long-term medical support and 
follow-up; current therapies are impractical for the majority of 
HCV carriers worldwide. The development of a protective 
vaccine remains, a distant goal [1].  
The aim of this study is to identify evolution model which 
estimates the mutation rate of non-structure 5B (NS5B) which 
has more variation (mutation) than other zones in Hepatitis C 
Virus genotype 4 subtype a (HCV4a) in Egypt.  Profile 
hidden markov model (PHMM), phylogenetic tree, a 
polynomial fitting and a least-square interpolation is used to 
outline the progression of the viral mutations over time. This 
model shall be used to predicate mutation rate of HCV in 
blood samples. The mutation model presents new therapeutic 
targets as well as genomic information for designing vaccine 
candidates. 
In this research the profile hidden markov model (PHMM) 
was identified as a technique to select sequence from many 
sequences observed in one year. A relationship between 
several sequences was deduced representing several years by 
estimating mutation rate using pair-wise distance method. The 
mutation model can predicate mutation rate for next year. Our 
approach introduces NS5B zone in HCV4a genome for 5 
years from 2007 to 2010. 
This paper is organized as follows: In section 2, related 
research for evolution of hepatitis C virus is presented. 
Section 3 describes HCV virus genome and explains the 
concept of the mutation rate. Section 4 presents the suggested 
method for evaluation of mutation rate. Section 5 presents the 
study data set and experimental results. Section 6 concludes 
the paper with future research directions. 
II. RELATED RESEARCH 
Several researches have been conducted to unravel 
information and useful patterns in a database for evolution of 
RNA and calculating mutation rate in HCV virus.  Pybus et 
al. [3] developed Bayesian inference framework to estimate 
the transmission dynamics of HCV in Egypt from sampled 
viral gene sequences, and to predict the public health impact 
of the virus. Bruijne et al. [4] investigates the genetic diversity 
and evolutionary origin of HCV-4 in Amsterdam, The 
Netherlands used a molecular epidemiological approach. 
Phylogenetic analysis of the NS5B sequences (668 bp) was 
obtained from 133 patients newly diagnosed with HCV-4 
infection over the period from 1999 to 2008. Xiong et al. [5] 
propose a stochastic model based on the branching process for 
estimation and comparison of the mutation rates in 
proliferation processes of cells or microbes. Barash et al. [6] 
introduce some Programs for RNA mutational analysis. These 
programs can be used for suggesting point mutations, 
investigating the effect of deleterious and compensatory 
mutations in allosteric ribozymes and riboswitches and 
analyzing regulatory RNA sequences by their mutational 
profile. Ribeiro et al. [7] measured the accumulative rate of 
mutations and fitted the model to the sequence data of HCV 
by estimating the median in vivo viral mutation rate.  
 
 
   
 
 
 
III. HCV VIRUS GENOME 
The HCV genome is an enveloped structure 
approximately 50 nm in diameter. HCV is a positive single 
stranded  enveloped RNA virus belonging to the Flaviviridae 
family with an average length of 9600 bases and carries a 
single, long open reading frame (ORF) flanked by 5' and 3' 
non-translated regions. The ORF encodes a polyprotein of ~ 
3000 amino acids that is processed into three structural 
proteins (Envelopes 1 and 2 and p7) and six non-structural 
proteins named NS2-NS5B [8 -9]. 
HCV is classified into eleven major genotypes (designated 
1-11), many subtypes (designated a, b, c, etc.), and about 100 
different strains (numbered 1, 2, 3, etc.) based on the genomic 
sequence heterogeneity. Genotype 4 (HCV4) is principally 
found in the Middle East and Africa, particularly Egypt, 
which represent more than 90% of infections due to genotype 
4 worldwide [9].  Ray et al. [10] characterize the genotype 
distribution of HCV in Egypt. In their work, specimens were 
obtained from blood donors in 15 geographically diverse 
governorates throughout Egypt. The result showed that 111 
(91%) were genotype 4, 1 (1%) was genotype 1a, 1 (1%) was 
genotype 1b, and 9 (7%) could not be typed. 
Definition of Mutation Rate 
A mutation is a change of the nucleotide sequence of the 
genome of an organism and virus. Mutation rate is a measure 
of the rate at which various types of mutations occur during 
some unit of time [11]. There are two units used in viral 
mutation rate. These units are related with the nature of the 
viruses replication. Viruses replication are one of two types: 
binary replication and Linear replication “stamping machine”. 
In case of binary replication, mutation rates are expressed as 
substitutions per nucleotide per strand copying unit. For linear 
replication mutation rates are expressed as substitutions per 
nucleotide per cell infection unit. HCV mutation rate is 
expressed with the last units [12]. In this paper mutation rate 
as substitutions per nucleotide per cell infection unit time was 
adopted. Reasons of mutations are from unrepaired damage to 
DNA or to RNA genomes (caused by radiation or chemical 
mutagens), from errors in the process of replication, or from 
the insertion or deletion of segments of DNA by mobile 
genetic elements. The high mutation rate in HCV is the reason 
of persistence in the human host [11].  
An accurate estimate of mutation rate of virus is very 
important to understand the evolution of the viruses and to 
combat them [12]. There are various statistical methods to 
estimate mutation rates.  It’s classified into three general 
approaches: linear regression, maximum likelihood, and 
Bayesian inference. Linear regression procedures calculate 
substitution rate by comparing directly genetic distance 
between two sequences with the interval separating their 
isolation times. These methods are fast and useful for 
visualizing new data sets. They can assist in model selection. 
But they make several limiting assumptions. Maximum 
likelihood (ML) approach defines methods that accommodate 
the time structure of temporally spaced sequences. ML 
methods are more sensitive and accurate than distance-based 
methods of linear regression.  In Bayesian statistical 
inference, substitution rate is obtained empirically from the 
frequency distribution of the parameters values sampled by 
the Markov chain Monte Carlo (MCMC) algorithm. 
Maximum likelihood and Bayesian methods utilize more 
information from the sequences and allow much more 
complex models of molecular evolution and demography to 
be investigated [13].  
One of linear regression methods is based on pair-wise 
distance [13]. Pair-wise distance enables to estimate distances 
in terms of the number of nucleotide substitutions.  In this 
paper two types of distances to measure the genetic distance 
between sequences are used: Jukes Cantor and Kimura.  
Jukes & Cantor distance: assumes all changes between all 
nucleotide are equally [14]. This is defined in equation (1)  
      (  ⁄ )     (    ⁄  )     (1) 
      = distance between sequence x and sequence y 
expressed as the number of changes per site, 
 D = is the observed proportion of nucleotides which differ 
between two sequences (fractional dissimilarity). 
 The 3/4 and 4/3 terms reflect that there are four types of 
nucleotides and three ways in which a second nucleotide   
Kimura method: this method distinguishes between two 
types of differences when comparing a pair of nucleotide 
sequences. Transition type which gets distance difference 
between nucleotide both are purines or both pyrimidines 
(TC, AG). The second type is transversion where the 
difference distance between one of the two is a purine and the 
other is a pyrimidine (TA, TG, CA, CG) [15].. This 
method is defined in equation (2) 
r   QQPK e 2121log21         (2) 
Where P and Q are the fractions of nucleotide sites of 
transition and transversion types respectively between two 
compared sequences. 
IV. EVOLUTION OF MUTATION RATE 
The objective of evolution model is to estimate mutation 
rate using Profile Hidden Markov Model (PHMM).  Where 
PHMM is a special type of left-to-right HMMs is commonly 
used to model multiple alignments. The architecture of 
PHMM was introduced by Krogh (1994) [16]. El Nahas et al. 
[9] define a tuple of HMM, its tasks, and the architecture of 
PHMM. 
The first step is to collect sequences from Egypt for 
several years.  The data collected from region NS5B 
sequences from HCV genotype 4 subtype a (HCV4a). Choice 
one sequence represent certain year from sequences collected 
to this year. This is done by using PHMM. The Baum Welch 
algorithm is generally accepted to estimate PHMM 
parameters. However, this algorithm assumes that the model 
length is known, which not the case in this work. Hence, we 
have to adapt the learning procedure to search for the optimal 
   
 
 
 
model length. The second step gathering all choice sequences 
and get matrix distance between each two sequences. 
Drawing these genetic distances and fitting it to get 
polynomial mutation rate. In this work MATLAB 
bioinformatics tool box functions was uses. The procedure is 
detailed in the following steps: 
Procedure Evaluate Mutation Rate 
Begin 
1- Input all sequences of each year of NS5B region 
of HCV4a. 
2- Apply Multiple Sequence Alignment (MSA) to 
these sequences of each year. MSA performs by 
using a heuristic search known as progressive 
technique (also known as the hierarchical or tree 
method).  
3- Preprocess data to filter unknown symbols. 
Sometimes, a characters ‘r, g, w, m, n, y, k, s’ is 
found in sequences which do not map to any of 4 
nucleotides (A, C, G, T) so it is replaced by one 
of nucleotide by using MSA. 
4- Initialize structure for PHMM of MSA. The 
initial model structure and length are defined 
using information derived from the alignment 
together with its prior knowledge of the general 
nature of proteins.  
5- Estimate the PHMM parameters from training 
sequences to each year. All the parameters in the 
PHMM (i.e. the transition probabilities and the 
nucleotide distributions) are estimated from a set 
of aligned sequences to maximize the likelihood  
of the observed sequences in the family.  The 
likelihood of observed sequences is defined as:  
P(sequences | model) = P(sequence 1| model) * … 
* P(sequence n |model) 
6- Score the model. Scoring is used to assign a 
score with respect to the model to any query 
sequence for each year, the better the score, the 
higher and the chance that the query sequence is a 
member (homologue) of the protein family 
represented by the model. Scores are computed 
using log-odd ratios for emission probabilities and 
log probabilities for state transitions.  
7- Computing the sequence Pair-Wise Distances. 
That is by constructing distance matrix which 
computes distances between each sequence pair. 
The method to calculate pair-wise distances is 
'Jukes-Cantor', which estimate Maximum 
likelihood of the number of substitutions between 
two sequences. Ignore sequence sites representing 
gaps. P is described with the method P-distance. 
Proportion of sites at which the two sequences are 
different. Note that P is close to 1 for poorly 
related sequences, and P is close to 0 for similar 
sequences.  
8- Construct a phylogenetic tree. Using distance 
matrix computed in step 7 to build the 
phylogenetic tree.  Where Phylogenetic trees 
represent evolutionary relationships, or 
genealogy, among species. The neighbor-joining 
method used to build the tree.  Assuming equal 
variance and independence of evolutionary 
distance estimates.  
9- Estimate the date of origin of the mutation. 
Consider the pair-wise distances according to the 
Kimura method, which distinguishes between 
transitional and tranversional mutation. Then, 
restrict analysis to the distance of each sequence 
from the reference year consider as the starting of 
the mutation. Plot the genetic distance versus the 
date of collection.  
10- Compute Progression of Viral Mutation. 
Perform a polynomial fitting and a least-square 
interpolation to outline the progression of the 
viral mutations over time. Which finds the 
coefficients of a polynomial p(x) of degree n 
that fits the data, p(x(i)) to y(i), in a least 
squares sense. The result p is a row vector of 
length n+1 containing the polynomial 
coefficients in descending powers. 
11- Reroute the Phylogenetic Tree. The rerouted tree 
better illustrates the progression of the 
NS5B(HCV4a) mutation starting with the early 
infections. 
end 
V. PILOT STUDY 
The main objective of this pilot study is to estimate the 
mutation rate of region NS5B in HCV4a spread in Egypt.  
Genotype 4 (HCV4) is particularly principally found in 
Egypt, which represent more than 90% of infections 
worldwide [12]. The region of NS5B in HCV4 subtype a 
(HCV4a) is used for this purpose. A data set representing 
NS5B is collected and used for to identify its mutation rate. 
Then, the learning procedure described in preceding section is 
applied on this real world data set to identify the model. 
A. Data Description 
The dataset contains the genomic sequences of distinct 
non-structural proteins named NS5B genotype 4 subtypes 4a 
from Egypt (11 sequences) in 2007 year, (35 sequences) in 
2008 year, (35 sequences) in 2009 year and (17 sequences) in 
2010 year. The length of the sequences varied between 286 
and 339 nucleotide (nt). The data is obtained from the site 
“http://www.ncbi.nlm.nih.gov/protein” and it is presented in 
Table 1 which contains virus sequence Number 
(Virus_seq_no) and genebank of each year. 
The data set was found to contain the characters ‘r, g, w, 
m,n, y, k, s’ which are undefined as nucleotide, to overcome 
this problem and to replace these undefined sites with suitable 
nucleotide  the following steps were applied 
1- Determine sequence number and positions numbers 
which contain these characters in original sequences. 
   
 
 
 
2- Apply  global alignment to all sequences MSA, and 
determine sequence number, position number of 
these characters and the most character repeated  
3- Replace these character with suitable nucleotide 
found in step 2. 
  
 
TABLE 1: The Data Set (http://www.ncbi.nlm.nih.gov/protein) 
Virus_seq_no Genbank_2007 
 
Virus_seq_no Genbank_2008 
 
Virus_eq_no Genbank_2009 
 
Virus_seq_no Genbank_2010 
2007_1  DQ911222  2008_1 EF694448  2009_1 AB470254  2010_1 FN668600 
2007_2  DQ911173   2008_2 EF694425  2009_2 AB470018  2010_2 FN668570 
2007_3  DQ911190   2008_3 EF694438  2009_3 AB470024  2010_3 FN668577 
2007_4  DQ911228   2008_4 EF694446  2009_4 AB470055  2010_4 FN668587 
2007_5  DQ911183   2008_5 EF694408  2009_5 AB470015  2010_5  FN668591 
2007_6  DQ911164   2008_6 EF694420  2009_6 AB470046  2010_6  FN668593 
2007_7  DQ911172   2008_7 EF694424  2009_7 AB470009  2010_7 FN668574 
2007_8  DQ911208   2008_8 EF694455  2009_8 AB470048  2010_8 FN668588 
2007_9  DQ911205   2008_9 EF694502  2009_9 AB470030  2010_9 FN668589 
2007_10 AY548725   2008_10 EF694517  2009_10 AB470036  2010_10  FN668586 
2007_11 DQ911206   2008_11 EF694456  2009_11 AB470019  2010_11 FN668583 
2007_12 AY548723   2008_12 EF694413  2009_12 AB470060      
2007_13  DQ911231   2008_13 EF694525  2009_13 AB470057     
2007_14 DQ911163   2008_14 EF694501  2009_14 AB470021     
2007_15 DQ911207   2008_15 EF694513  2009_15 B470039     
2007_16 AY548722   2008_16 EF694498  2009_16 AB470028     
2007_17 DQ911218   2008_17 EF694396  2009_17 AB470008     
     2008_18 EF694486  2009_18 AB470014     
   2008_19 EF694450  2009_19 AB470037     
   2008_20 EF694418  2009_20 AB470027     
   2008_21 EF694439  2009_21 AB470052     
   2008_22 EF694434  2009_22 AB470043     
   2008_23 EF694442  2009_23 AB470049     
   2008_24 EF694440  2009_24 AB470026     
   2008_25 EF694493  2009_25 AB470006     
   2008_26 EF694499  2009_26 AB470053     
   2008_27 EF694445  2009_27 AB470013     
   2008_28 EF694463  2009_28 AB470023     
   2008_29 EF694505  2009_29 AB470005     
   2008_30 EF694476  2009_30 AB470007     
   2008_31 EF694475  2009_31 AB470056     
   2008_32 EF694433  2009_32 AB470017     
   2008_33 EF694478  2009_33 AB470059     
   2008_34 EF694459  2009_34 AB470252     
   2008_35 EF694524  2009_35 AB470033     
B. Experimental Results 
Table 2 shows scores of PHMM model applied to all sequences of 2007 to 2010 years on NS5B of HCv4a. Scores show that 
the sequences 11, 9, 14 and 10 are more suitable candidate sequences of 2007, 2008, 2009 and 2010 years respectively. 
  
TABLE 2: Scores of sequences in each year to PHMM model 
    
  2007 2008 2009 2010 
  Seq_11 Seq_9 Seq_14 Seq_10 
N
u
m
b
er
  
o
f 
M
at
ch
 s
ta
te
s 
(l
en
g
th
 o
f 
th
e 
m
o
d
el
) 
200 173.2023 290.6751 305.7761 112.8878 
210 189.8152 317.9683 318.7579 122.2278 
220 206.9295 334.3079 328.1445 126.6255 
230 223.6203 350.1565 342.7904 132.7961 
240 240.3303 363.4668 356.4055 153.8358 
250 254.2443 377.1032 369.6046 170.5305 
260 270.6948 388.6816 385.3829 189.7923 
270 288.0402 402.3539 394.7695 209.4087 
280 305.6335 415.4973 405.1091 228.9011 
290 321.3509 425.3251 418.0684 249.4041 
300 337.0683 436.9035  269.9071 
310 353.6787 446.3764  290.6723 
320 365.4927 457.7152  301.4251 
330 369.5766    
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Table 3 and Figure 1 show the scores of pair-wise 
distances using Juke-cantor correction expressed in a 
symmetric matrix.  
 
 
 
 
TABLE 3: Pair-Wise Distances using Jack-cantor 
corrections 
  2007 2008 2009 2010 
Y
ea
rs
 
2007 0 0.1077 0.1942 0.1009 
2008 0.1077 0 0.184 0.0579 
2009 0.1942 0.184 0 0.1956 
2010 0.1009 0.0579 0.1956 0 
 
Figure 1 Construct score of genetic distances versus years 
 
 
Figure 2 shows a phylogenetic tree of Table 3. The 
distance difference between 2008 and 2010 years is 0.0579 
which is the least distance record in Table 3. Hence these two 
years are represented as on cluster. Year 2009 records high 
difference distance with respect to all years, so it is 
considered as one cluster as shown in Figure 2. 
 
Figure 2 Neighbor-Joining Phylogenetic tree 
Table 4 shows pair-wise distances using Kimura method. 
Estimate the date of origin of the mutation is 3/23/ 2007. 
Restrict analysis to the distance of each sequence to this year. 
Figure 3 plots the genetic distance versus this year, which 
shows that the minimum distance recorded is 0.0424 to 2009 
year respect to 2007 year. The maximum distance recorded is 
0.0589 to 2008 year with respect to 2007 year. 
 
 
 TABLE 4: Pair-Wise Distances using Kimura model  
  2007 2008 2009 2010 
Y
ea
rs
 
2007 0 0.0589 0.0424 0.0515 
2008 0.0589 0 0.0288 0.0584 
2009 0.0424 0.0288 0 0.0397 
2010 0.0515 0.0584 0.0397 0 
 
Figure 3 Genetic distances with respect to the year of 2007 
 
Figure 4 shows a polynomial fitting of progression of viral 
mutation from scores in genetic distance in Figure 3. These 
scores increase approximately in a linear manner with time. 
The polynomial equation is found to be:  
D = 0.00004493 X+0.008826         (5.1) 
where  0.00004493 is the mutation rate(slope),  0.008826 
is the intercept, 
      and D the is any genetic distance (score) referred to 
year of 2007 and X is the time relative to the reference year . 
 
Figure 4 Progression of Viral Mutation with respect to the year of 2007 
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Figure 5 shows rerouting the phylogenetic tree of 
NS5B(HCV4a). This illustrates the progression of the 
mutation of the virus. 95% confidence interval of the 
estimated polynomial is also plotted in red color on the Figure 
5. 
 
 
Figure 5 Rerouting Neighbor-Joining Phylogenetic tree 
 
VI. CONCLUSION AND FUTURE WORK 
In this paper, the model based framework for estimation of 
mutation rate of NS5B region of (HCV4a) in Egypt for 
several years is introduced. The framework is based on 
building  phylogenetic tree from time tagged  PHMM  
models.  A learning process of PHMM model is used to select 
one sequence from all sequences collected in any year. Then 
scores based on genetic distance between any two sequences 
of selected sequences is calculated.  Estimation of mutation 
rate of selected sequences is calculated by fitting the scores 
refereed to the 2007 year. The mutation rate is estimated as 
0.00004493  substitutions per nucleotide per year. This 
approach combines both the speed of regression methods and 
the accuracy of statistical methods for evaluation of virus 
mutation rate. The future work shall study the mechanism of 
the virus mutation between all sequences and between the 
positions. 
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